```json
{
"content": [
{
"type": "paragraph",
"content": "Systemic Aspergillosis market taxonomy reveals distinct application and types segments. In terms of application, hospitals dominate with 55% market share, driven by advanced diagnostic facilities and treatment protocols. Outpatient clinics account for 30%, supporting long-term management of chronic cases, while diagnostic labs capture 15% through early detection services. Types segmentation is anchored by Invasive Aspergillosis, which constitutes 70% of the market due to its high mortality rate and intensive treatment requirements, and Chronic Pulmonary Aspergillosis, contributing 30% through prolonged antifungal therapies. This segmentation underscores the market’s reliance on acute care settings and the economic burden of invasive infections."
},
{
"type": "paragraph",
"content": "Systemic Candidasis market taxonomy highlights application and types as key drivers. Application is led by hospitals (60%), where immunocompromised patients and ICU care dominate treatment, followed by outpatient settings (25%) for follow-up and home healthcare (15%) for self-administered antifungal regimes. Types segmentation is split between Invasive Candidiasis, which holds 80% of the market due to its severity and high healthcare costs, and Cutaneous Candidiasis, accounting for 20% via over-the-counter antifungal products. The dominance of invasive forms reflects systemic Candidasis’s association with hospital-acquired infections and high mortality rates."
}
],
"chartData": {
"segments": [
{ "name": "Hospitals", "value": 57.5 },
{ "name": "Outpatient Clinics", "value": 27.5 },
{ "name": "Home Healthcare", "value": 15 }
]
}
}
```
